Clinical Trial Update: A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3 trial to evaluate finerenone versus placebo on standard treatment for safety, pharmacokinetics, and efficacy in children with heart failure and left v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Left Ventricular Systolic Dysfunction

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Bayer | Conditions: Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | Phase 3 | Status: RECRUITING